GMACPHARMA is a trusted partner to pharma biotech and cell therapy companies, specialising in tech transfer and CDMO 3rd party network management for clinical supply, market launch and routine commercial supply. With deep expertise from over 50 successfully executed US-to-EU tech transfers, we are well placed to help organisations onshore manufacturing capacity in the US. We guide organisations, taking a systematic hands-on approach based on experience to optimise timelines . Our team complements leaders navigating complex regulatory and commercial landscapes with particular expertise of US FDA markets. GMACPHARMA also provides strategic business development, working closely with clients to define and execute rapid growth and tech transfer visions for time, budget and market-sensitive success. For companies pursuing investment, sale, or IPO, we deliver compliance due diligence support.
Pipeline to patient; GMACPHARMA delivers insight, structure, and execution as prerequisites for success in complex biotech tech transfers into US and global in-house and 3rd party manufacturing networks.